AD

Adcendo

<UNKNOWN>, DK · 2 known investors

adcendo.dk ↗

Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs. The company translates scientific innovation into clinically differentiated medicines for patients with advanced solid tumors and other cancer types.

Investors · 2

VI

Vida Ventures✓ verifiedLos Angeles

YS

Ysios CapitalDenmark